Open AccessRisk stratification in ambulatory patients with heart failure and chronic obstructive pulmonary disease: evaluation of predictive value of standard prognostic markers for 5-years survival
Author(s) -
M. Yu. Sitnikova,
T. A. Lelyavina,
П. А. Федотов,
М. А. Трукшина,
В. В. Дорофейков,
E. V. Shlyakhto
Publication year - 2009
Publication title -
arterialʹnaâ gipertenziâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.126
H-Index - 5
eISSN - 2411-8524
pISSN - 1607-419X
DOI - 10.18705/1607-419x-2009-15-2-132-137
Subject(s) - medicine , cardiology , ejection fraction , heart failure , copd , brain natriuretic peptide
The purpose of the study was to assess the predictive value of standard prognostic markers in ambulatory patients with heart failure (HF) and chronic obstructive pulmonary disease (COPD) discharged after heart failure hospitalization. We used prospectively collected information, including medical history, physical examination, 6-minute walking test, chest X-ray, electrocardiogram, echocardiography, blood test (including brain natriuretic peptide (BNP)) (totally 450 variables) in 98 hospitalized patients 45-65 years old (mean age 61 ± 0,8 years, 75 men), with NYHA class HF II-IV, COPD 2-4 stage. After hospital discharge all patients were followed up by cardiologists specialized in HF for a mean period of 5 years. Correlation analysis was used to assess the predictive value of standard prognostic markers. 5-year survival was 81 %. Prognostic markers including older age, ischemic aetiology of HF, diabetes mellitus, angiotensine converting enzyme-inhibitors and β-blockers therapy, tachycardia, low blood pressure, low body mass index, marked elevation of BNP, creatinine, bilirubin, anemia, hyponatriemia, low left ventricular ejection fraction, restrictive mitral filling pattern had no influence on 5-year survival in HF patients with COPD.